Effect of Ondansetron in Pain and Nausea
Phase 3
- Conditions
- Pain, nausea and discomfort from nasal-gastric tube insertion.
- Registration Number
- IRCT20180717040509N5
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Patients with NG tube Indication
Exclusion Criteria
less than 18 years old
Unconsciousness
Patients with unstable hemodynamic status (systolic blood pressure less than 90 mmHg)
Having a nose bleed
Anatomical problems in the nose
Traumatic patients
Sensitivity to Ondansetron
Use of Ondansetron interfering drugs (anticholinergic, digoxin, levodopa, tetracycline)
Pregnancy
Patients with nausea and vomiting problem
NG tube more than twice
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain, nausea and discomfort. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.
- Secondary Outcome Measures
Name Time Method Bleeding and vomiting after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score.